Emerging Weight Loss Drugs and What Pharmacies Need to Know Pharmacy Mentor Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Semaglutide, Tirzepatide, Retatrutide and Cagrilintide are often lumped together, but they are not doing the same thing. : r Wegovy Pipeline Report 2025: Late stage programs set to reshape treatment . , One of the biggest mistakes I see is assuming that if someone cannot tolerate a GLP 1, there are no other options. Thats